Kevin M. Slawin, Director at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 30,000 shares at $12.54 ($376K) on 2017-02-07, disclosed to the SEC on 2017-02-09.
Open-market sale of $376k BLCM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BLCM | SELL | 2016-09-20 | $92K | — | Filing → |
| BLCM | SELL | 2016-08-17 | $2.0M | — | Filing → |
| BLCM | SELL | 2016-07-29 | $225K | — | Filing → |